Holen Sie sich die Stockscreener-App
2.43
5.08%
-0.13
Schlusskurs vom Vortag:
$2.56
Offen:
$2.56
24-Stunden-Volumen:
550.38K
Relative Volume:
0.50
Marktkapitalisierung:
$220.88M
Einnahmen:
$78.09M
Nettoeinkommen (Verlust:
$-31.99M
KGV:
-6.6942
EPS:
-0.363
Netto-Cashflow:
$-22.12M
1W Leistung:
-1.62%
1M Leistung:
+3.40%
6M Leistung:
+48.17%
1J Leistung:
-21.86%
1-Tages-Spanne:
$2.37
$2.57
1-Wochen-Bereich:
$2.37
$2.695
52-Wochen-Spanne:
$0.9583
$3.87
Codexis Inc Stock (CDXS) Company Profile
Firmenname
Codexis Inc
Sektor
Branche
Telefon
650-421-8100
Adresse
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Compare CDXS vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.43 | 220.88M | 78.09M | -31.99M | -22.12M | -0.363 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-01 | Eingeleitet | Stifel | Buy |
| 2021-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-10 | Eingeleitet | The Benchmark Company | Buy |
| 2019-01-17 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Eingeleitet | Stephens | Overweight |
| 2017-10-13 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-31 | Eingeleitet | Jefferies | Buy |
| 2017-01-26 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Codexis Inc Aktie (CDXS) Neueste Nachrichten
CDXS Q1 2026 Earnings: EPS Surpasses Estimates by 28.26%, Shares RiseUpward Estimate Revision - dars.gov.et
Price to earnings forward of Codexis, Inc. – NASDAQ:CDXS - TradingView
CDXS News | CODEXIS INC (NASDAQ:CDXS) - ChartMill
CDXS Stock Price, Quote & Chart - ChartMill
Codexis Inc. (CDXS) Slips 2.5% as Shares Test Key Support LevelsVirgin POC - dars.gov.et
Enterprise value to revenue forward of Codexis, Inc. – NASDAQ:CDXS - TradingView
Enterprise value to EBITDA forward of Codexis, Inc. – NASDAQ:CDXS - TradingView
US$6.58: That's What Analysts Think Codexis, Inc. (NASDAQ:CDXS) Is Worth After Its Latest Results - 富途牛牛
Price to book forward of Codexis, Inc. – NASDAQ:CDXS - TradingView
Price to book forward of Codexis, Inc. – LSX:A0Q2S4 - TradingView
Codexis, Inc. Actuals & Estimates (NASDAQ:CDXS) - TradingView
CDXS Forecast — Price Target — Prediction for 2027 - TradingView
Codexis Inc (CDXS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why Did CDXS Stock Jump 7% Today? - Stocktwits
Codexis Inc (CDXS) Institutional Confidence - TradingKey
Codexis, Inc. 2026 Annual Meeting Results: Shareholder Votes and SEC Filing Summary - Minichart
Codexis Shareholders Back Board Slate and Governance Measures - TipRanks
Form 8K Codexis Inc For: 22 June By Investing.com - Investing.com South Africa
Codexis shareholders elect directors and approve proposals at annual meeting - Investing.com Nigeria
Codexis (CDXS) shareholders back board nominees, KPMG and pay plan - Stock Titan
Codexis | 4: Statement of changes in beneficial ownership of securities-Director PARKER H STEWART - Moomoo
Codexis (CDXS) director Parker H. Stewart receives 66,350 stock options - Stock Titan
Codexis | 4: Statement of changes in beneficial ownership of securities-Director Collins Cynthia - Moomoo
Director at Codexis (CDXS) receives 66,350 stock options grant - Stock Titan
CODEXIS (CDXS) director receives 66,350 stock options at $2.48 strike price - Stock Titan
Codexis | 4: Statement of changes in beneficial ownership of securities-Director Smith David V - Moomoo
Codexis (CDXS) director David V. Smith granted 66,350 stock options at $2.48 - Stock Titan
Codexis (NASDAQ: CDXS) director receives 66,350 options vesting in one year - Stock Titan
Codexis (CDXS) director receives option grant for 66,350 shares - Stock Titan
Codexis (CDXS) grants director 66,350 stock options at $2.48 - Stock Titan
Codexis (CDXS) director Raymond De Vre awarded 66,350 stock options at $2.48 - Stock Titan
Codexis Inc (CDXS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Codexis Inc (CDXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Codexis Inc (CDXS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Codexis Inc (CDXS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Codexis Inc (CDXS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Codexis Inc (CDXS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Codexis Inc (CDXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CDXS: All proposals, including director elections and auditor ratification, were approved without contest - TradingView
Codexis Inc Annual Shareholders Meeting Transcript - GuruFocus
Cantor Fitzgerald reiterates Codexis stock rating on oligo platform - Investing.com
Cantor Fitzgerald reiterates Codexis stock rating on oligo platform By Investing.com - Investing.com Canada
CDXS Q1 2026 Earnings: EPS Surprises to the Upside, Stock GainsNon-GAAP Earnings - dars.gov.et
CDXS Q1 2026 Earnings: EPS Beats Estimates as Company Shows Operational ProgressEPS Revision Trend - newsline.com
CDXS Q1 2026 Earnings: EPS Beats Estimates by 28.26% Despite Revenue UncertaintiesMargin Improvement Report - newsline.com
Codexis (CDXS) Hovers Near Support as Consolidation ContinuesExtension Target - newsline.com
Codexis director Raymond de Vre sells $6,173 in shares - Investing.com UK
Codexis director Raymond de Vre sells $6,173 in shares By Investing.com - Investing.com Nigeria
Codexis (CDXS) director De Vre sells 2,605 shares to cover RSU tax liability - Stock Titan
CDXS Q1 2026 Earnings: EPS Beat Despite Revenue Uncertainty, Shares SlipOperating Income Trends - newsline.com
CDXS Q1 2026 Earnings: EPS Surprise of 28% Fails to Offset Revenue UncertaintyEarnings Revision Downgrade - newsline.com
Finanzdaten der Codexis Inc-Aktie (CDXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):